CD4 Inhibits Helper T Cell Activation at Lower Affinity Threshold for Full-Length T Cell Receptors Than Single Chain Signaling Constructs

Autor: Taylor S. Orton, Stephen P. Persaud, Wyatt Magoffin, Sheldon J Myers, John C Hancock, K. Scott Weber, Kenneth A. Christensen, Deborah K. Johnson, Jordan G. Finnell
Rok vydání: 2020
Předmět:
lcsh:Immunologic diseases. Allergy
T cell
Receptors
Antigen
T-Cell
alpha-beta

Immunology
chemical and pharmacologic phenomena
Mice
Transgenic

Lymphocyte Activation
Immunotherapy
Adoptive

Mice
Immune system
Antigens
Neoplasm

Transduction
Genetic

Yeasts
medicine
Immunology and Allergy
Animals
Original Research
Hybridomas
Receptors
Chimeric Antigen

chimeric antigen receptor
Chemistry
T-cell receptor
Histocompatibility Antigens Class II
Models
Immunological

hemic and immune systems
T-Lymphocytes
Helper-Inducer

Tumor antigen
Chimeric antigen receptor
CD4
Cell biology
Lck
Mice
Inbred C57BL

medicine.anatomical_structure
Lymphocyte Specific Protein Tyrosine Kinase p56(lck)
helper T cell
Cancer cell
CD4 Antigens
Interleukin-2
affinity
T cell receptor
lcsh:RC581-607
Intracellular
CD8
Signal Transduction
Zdroj: Frontiers in Immunology
Frontiers in Immunology, Vol 11 (2021)
ISSN: 1664-3224
Popis: CD4+ T cells are crucial for effective repression and elimination of cancer cells. Despite a paucity of CD4+ T cell receptor (TCR) clinical studies, CD4+ T cells are primed to become important therapeutics as they help circumvent tumor antigen escape and guide multifactorial immune responses. However, because CD8+ T cells directly kill tumor cells, most research has focused on the attributes of CD8+ TCRs. Less is known about how TCR affinity and CD4 expression affect CD4+ T cell activation in full length TCR (flTCR) and TCR single chain signaling (TCR-SCS) formats. Here, we generated an affinity panel of TCRs from CD4+ T cells and expressed them in flTCR and three TCR-SCS formats modeled after chimeric antigen receptors (CARs) to understand the contributions of TCR-pMHCII affinity, TCR format, and coreceptor CD4 interactions on CD4+ T cell activation. Strikingly, the coreceptor CD4 inhibited intermediate and high affinity TCR-construct activation by Lck-dependent and -independent mechanisms. These inhibition mechanisms had unique affinity thresholds dependent on the TCR format. Intracellular construct formats affected the tetramer staining for each TCR as well as IL-2 production. IL-2 production was promoted by increased TCR-pMHCII affinity and the flTCR format. Thus, CD4+ T cell therapy development should consider TCR affinity, CD4 expression, and construct format.
Databáze: OpenAIRE